Company news
Medical Marijuana, Inc. (OTC:MJNA) news
Medical Marijuana, Inc. news releases on 6ix. Latest, Jan 29, 2026: Medical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance…
Press releases & updates
Medical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
January 29, 2026
AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
January 29, 2026
EQS-News: Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research
June 25, 2024
Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
July 31, 2023
Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
March 13, 2023
Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries
February 6, 2023
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
January 24, 2023
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
November 29, 2022
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
November 22, 2022
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
November 1, 2022
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia
October 20, 2022
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment
October 12, 2022
Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President
October 4, 2022
Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region
September 8, 2022
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results
August 18, 2022
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil
August 11, 2022
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News
July 26, 2022
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Health & Wellness Podcast; Secures Features in Top Brazil Lifestyle Publications
July 14, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in June 2022
July 12, 2022
Medical Marijuana, Inc. Subsidiary HempMeds® Collaborates With Leading Research Hospital in Argentina to Study the Efficiency of CBD for Adult Epilepsy
July 6, 2022
Medical Marijuana, Inc. Subsidiary Kannaway Hosts Regional Conference in South Africa
June 30, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in May 2022
June 14, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Recent Federal Court Ruling on Delta-8 THC; Launches New Hemp Products
May 31, 2022
Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies
May 26, 2022
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Feature in Forbes
May 23, 2022
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results
May 19, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare CBD Safety Study
May 18, 2022
Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company
May 12, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Direct Sales Veteran Eric Glenn as Entrepreneur
May 11, 2022
Medical Marijuana, Inc. Honored as Silver Stevie Award Winner in the 2022 American Business Awards®
April 28, 2022
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Exponential Growth; Receives Validation From Medical Community
April 21, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa Division in March 2022
April 14, 2022
Medical Marijuana, Inc. Provides Update on its Pharmaceutical Initiatives
April 7, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Included on New FSA List of CBD Novel Food Applicants
April 4, 2022
Medical Marijuana, Inc. Reports $34.1 Million in Revenue in 2021 Annual Financial and Operational Results Filing
April 1, 2022
Medical Marijuana, Inc. Issues New Letter to Shareholders
March 29, 2022
Medical Marijuana, Inc. Satisfies Major Outstanding Convertible Debt
March 10, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Leadership & Product Launch Event in Prague
March 1, 2022
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors First Brazilian Obesity Medicine Symposium
February 24, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa and Japan Divisions in January 2022
February 15, 2022
Medical Marijuana, Inc. Promotes Chief Financial and Information Officer Todd Morrow to Company President
February 10, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Opens New Office and Warehouse in Johannesburg, South Africa
February 1, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Opens Distribution Center in Hong Kong
January 25, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Hires Jeanne Rawdin to Lead Company's Global Communications
January 18, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Opens New Office and Warehouse in Warsaw, Poland
January 12, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates New Milestone; Achieves Best Revenue Month in Company History for Japan Division in December 2021
January 4, 2022
Medical Marijuana, Inc. Subsidiary Kannaway® Announces November 2021 as the Best Month in Company History for Japan Division
December 8, 2021
Medical Marijuana, Inc. Subsidiary Kannaway Hires Jose Miguel Gutierrez Vazquez
December 6, 2021
Medical Marijuana, Inc. CEO Featured on Seeking Alpha’s CEO Interviews Podcast
November 24, 2021
Medical Marijuana, Inc. Subsidiary Kannaway® Begins Building South Africa Operations; Hires Duduzile Mathole as Country Manager
November 22, 2021